Serial 79168971
Live / Registered — International registration cancelled — extension of protection cancelled (as of 17 Dec 2024)
What this means for you
Registered since 14 Jun 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79168971
- Registration number
- 4975416
- Mark type
- Design / logo
- Filed
- 17 Dec 2014
- Published for opposition
- 29 Mar 2016
- Registered
- 14 Jun 2016
- Attorney of record
- Bryce J. Maynard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for the testing, diagnosis, prevention or treatment of drug dependency, substance addiction, poisoning, overdose, envenomation, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders
- Class 042 — Scientific and technological services: Scientific research for medical purposes in the fields of allergies, drug dependency, substance addiction, autoimmune disease, poisoning, overdose, envenomation transplant rejection, immunodeficiency disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders; medical and pharmacological research services in the fields of allergies, drug dependency, substance addiction, autoimmune disease, poisoning, overdose, envenomation, transplant rejection, immunodeficiency disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceutical and clinical trials; conducting clinical trials for others; information, advisory and consultancy services relating to the aforesaid
Owner
- Circassia Limited, GB
- Circassia Limited, GB
- Circassia Limited, GB
Prosecution history
- 11 Jul 2025 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 11 Jul 2025 — DEATH OF INTERNATIONAL REGISTRATION
- 09 Oct 2023 — TOTAL INVALIDATION PROCESSED BY THE IB
- 16 Sept 2023 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 16 Sept 2023 — INVALIDATION PROCESSED
- 30 Aug 2023 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 30 Dec 2022 — CANCELLED SECTION 71
- 04 Dec 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 14 Jun 2021 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 25 Oct 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 13 Oct 2016 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Sept 2016 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Sept 2016 — FINAL DISPOSITION PROCESSED
- 14 Sept 2016 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 14 Jun 2016 — REGISTERED-PRINCIPAL REGISTER